Objectives:

  • Identify the emerging role of quadruplet regimens in the treatment of newly diagnosed multiple myeloma
  • Analyze the emerging trends in MGUS assessment and the potential risks and benefits of MGUS screening
  • Outline the potential role of menin inhibitors in acute leukemia therapy.

Zoom Info:

Join from a PC, Mac, iPad, iPhone or Android device:

    Please click this URL to join. https://uwmadison.zoom.us/s/94681614650?pwd=MFBVNHRGWTB6OFRVWnQzemN6ZGJsZz09 Passcode: Grand

Or One tap mobile: +16469313860,,94681614650# US; +19292056099,,94681614650# US (New York)

Or join by phone: Dial(for higher quality, dial a number based on your current location):

US: +1 646 931 3860  or +1 929 205 6099  or +1 301 715 8592  or +1 305 224 1968  or +1 309 205 3325  or +1 312 626 6799  or +1 386 347 5053  or +1 507 473 4847  or +1 564 217 2000  or +1 669 444 9171  or +1 669 900 6833 

    Webinar ID: 946 8161 4650; International numbers available: https://uwmadison.zoom.us/u/acbMvfbUhT

Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East); Webinar ID: 946 8161 4650; Passcode: 430560

SIP: 94681614650@zoomcrc.com; Passcode: 430560

Session date: 
01/31/2024 - 8:00am to 9:00am CST
Location: 
In-person and Virtually
750 Highland Avenue (HSLC)
HSLC 1306
Madison, WI 53705
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 ACPE Contact Hours - Pharmacist Technician
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Natalie Callendar
Dr. Aric Hall
Dr. Timothy Schmidt
Dr. Matthew Brunner